Terms: = Liver cancer AND KMT2D, ENSG00000167548, 8085, MLL2 AND Treatment
13 results:
1. Comparative Clinicopathologic and Genomic Analysis of Hepatocellular Neoplasm, Not Otherwise Specified, and Hepatoblastoma.
Zhou S; Sarabia SF; Estrine D; Ostrow D; Schmidt RJ; Warren M; Raca G; Shillingford N; Wang L; Pawel B; Stein JE; Biegel JA; Lopez-Terrada D; Mascarenhas L; Ji J
Mod Pathol; 2024 Feb; 37(2):100385. PubMed ID: 37992967
[TBL] [Abstract] [Full Text] [Related]
2. Interaction of MRPL9 and GGCT Promotes Cell Proliferation and Migration by Activating the MAPK/ERK Pathway in Papillary Thyroid cancer.
Zhang HM; Li ZY; Dai ZT; Wang J; Li LW; Zong QB; Li JP; Zhang TC; Liao XH
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233293
[TBL] [Abstract] [Full Text] [Related]
3. Genomic alterations and possible druggable mutations in carcinoma of unknown primary (CUP).
Es HA; Mahdizadeh H; Asl AAH; Totonchi M
Sci Rep; 2021 Jul; 11(1):15112. PubMed ID: 34302033
[TBL] [Abstract] [Full Text] [Related]
4. treatment landscape of metastatic pancreatic cancer.
De Dosso S; Siebenhüner AR; Winder T; Meisel A; Fritsch R; Astaras C; Szturz P; Borner M
Cancer Treat Rev; 2021 May; 96():102180. PubMed ID: 33812339
[TBL] [Abstract] [Full Text] [Related]
5. [State of the art in the diagnostics of hepatocellular carcinoma and current treatment options].
Ringe KI; Hinrichs JB
Radiologe; 2021 Feb; 61(2):213-226. PubMed ID: 33464405
[TBL] [Abstract] [Full Text] [Related]
6. Management of Very Late Pancreatic Metastasis of Renal Cell Carcinoma 8 Years After Radical Nephrectomy: A Report of a Rare Case.
Alayyaf N; AlQatari AA; Altalib A; AlQattan AS; Alshahrani AA
Am J Case Rep; 2021 Jan; 22():e927921. PubMed ID: 33400693
[TBL] [Abstract] [Full Text] [Related]
7. Mutations in circulating tumor DNA predict primary resistance to systemic therapies in advanced hepatocellular carcinoma.
von Felden J; Craig AJ; Garcia-Lezana T; Labgaa I; Haber PK; D'Avola D; Asgharpour A; Dieterich D; Bonaccorso A; Torres-Martin M; Sia D; Sung MW; Tabrizian P; Schwartz M; Llovet JM; Villanueva A
Oncogene; 2021 Jan; 40(1):140-151. PubMed ID: 33097857
[TBL] [Abstract] [Full Text] [Related]
8. Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas.
Ding X; He M; Chan AWH; Song QX; Sze SC; Chen H; Man MKH; Man K; Chan SL; Lai PBS; Wang X; Wong N
Gastroenterology; 2019 Dec; 157(6):1630-1645.e6. PubMed ID: 31560893
[TBL] [Abstract] [Full Text] [Related]
9. Comprehensive cancer Panel Sequencing Defines Genetic Diversity and Changes in the Mutational Characteristics of Pancreatic cancer Patients Receiving Neoadjuvant treatment.
Yoon KA; Woo SM; Kim YH; Kong SY; Lee MK; Han SS; Kim TH; Lee WJ; Park SJ
Gut Liver; 2019 Nov; 13(6):683-689. PubMed ID: 30970447
[TBL] [Abstract] [Full Text] [Related]
10. IgG4-associated cholangitis.
Beuers U; Maillette de Buy Wenniger LJ; Doorenspleet M; Hubers L; Verheij J; van Gulik T; van de Graaf SF; de Vries N
Dig Dis; 2014; 32(5):605-8. PubMed ID: 25034294
[TBL] [Abstract] [Full Text] [Related]
11. Evolving frequency and outcomes of liver transplantation based on etiology of liver disease.
Singal AK; Guturu P; Hmoud B; Kuo YF; Salameh H; Wiesner RH
Transplantation; 2013 Mar; 95(5):755-60. PubMed ID: 23370710
[TBL] [Abstract] [Full Text] [Related]
12. Perioperative reactivation of hepatitis B virus replication in patients undergoing partial hepatectomy for hepatocellular carcinoma.
Huang L; Li J; Lau WY; Yan J; Zhou F; Liu C; Zhang X; Shen J; Wu M; Yan Y
J Gastroenterol Hepatol; 2012 Jan; 27(1):158-64. PubMed ID: 21871026
[TBL] [Abstract] [Full Text] [Related]
13. Conditionally cleavable radioimmunoconjugates: a novel approach for the release of radioisotopes from radioimmunoconjugates.
Beeson C; Butrynski JE; Hart MJ; Nourigat C; Matthews DC; Press OW; Senter PD; Bernstein ID
Bioconjug Chem; 2003; 14(5):927-33. PubMed ID: 13129395
[TBL] [Abstract] [Full Text] [Related]
